AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Next Generation Sequencing Market 2019-2023 | Evolving Opportunities with Illumina Inc. and Invitae Corp. | Technavio

November 22, 2019
Global Next Generation Sequencing Market 2019-2023 | Evolving Opportunities with Illumina Inc. and Invitae Corp. | Technavio
Global Next Generation Sequencing Market 2019-2023 | Evolving Opportunities with Illumina Inc. and Invitae Corp. | Technavio

LONDON--(BUSINESS WIRE)--Nov 22, 2019--

Technavio has been monitoring the global next generation sequencing market since 2015 and the market is poised to grow by USD 5.67 billion during 2019-2023 at a CAGR of over 19% during the forecast period. Request Free Sample Pages

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191122005423/en/

Technavio has announced its latest market research report titled global next generation sequencing market 2019-2023. (Graphic: Business Wire)

Read the 152-page research report with TOC on “Next Generation Sequencing Market Analysis Report by Technology (SBS, Ion torrent semiconductor sequencing, SMRT sequencing, and Nanopore sequencing), Product (Consumables and Equipment), End-users (Research institutes and Commercial entities), and Geography (Asia, Europe, North America, and ROW), and Segment Forecasts, 2019 - 2023”.

The market is driven by the growing demand for early diagnosis of genetic disorders. In addition, the reduced cost of gene sequencing is anticipated to further boost the growth of the next generation sequencing market.

Specific procedures used in instances of artificial insemination and in vitro fertilization (IVF) involve early diagnosis to help to prevent health conditions and physical disabilities in newborns. This is encouraging vendors to introduce products such as Ion ReproSeq preimplantation genetic screening (PGS) Kit, which is based on the ion torrent sequencing technology. A common genetic defect, aneuploidy, can be determined by a screening method, preimplantation genetic testing for aneuploidy (PGT-A) and next generation sequencing (NGS) for complete analysis. Thus, the growing demand for early diagnosis of genetic disorders is expected to drive market growth during the forecast period.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five Next Generation Sequencing Market Companies:

Bio-Rad Laboratories Inc.

Bio-Rad Laboratories Inc. is headquartered in the US and operates the business under various segments such as Life Science and Clinical Diagnostics. The company offers QX200 Droplet Digital PCR System as an automated PCR system.

Eurofins GSC Lux Sarl

Eurofins GSC Lux Sarl is headquartered in Luxembourg and offers products through the following business units: Benelux, France, Germany, North America, Nordic Region, UK and Ireland, and Other. The company offers INVIEW De Novo Genome 2.0 to its customers.

F. Hoffmann-La Roche Ltd.

F. Hoffmann-La Roche Ltd. is headquartered in Switzerland and operates under various business segments, namely Pharmaceuticals and Diagnostics. The company offers NGS Oncology Assays to end-users such as laboratories and clinics.

Illumina Inc.

Illumina Inc. is headquartered in the US and offers products through the following business segments: Core Illumina and Consolidated VIEs. The company offers Nextera XT DNA Library Preparation Kit as a kit to prepare sequencing libraries.

Invitae Corp.

Invitae Corp. is headquartered in the US and offers products through the unified business segment. The company offers Invitae Boosted Exome test, which provides a clear evidence-based analysis of an individual’s exome.

Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform

Next Generation Sequencing Product Outlook (Revenue, USD Million, 2019 - 2023)

Next Generation Sequencing Regional Outlook (Revenue, USD Million, 2019 - 2023)

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.Request a free sample report

Related Reports on Health Careinclude:

Genetic Testing Market – Global Genetic Testing Market by geography (Asia, Europe, North America, and ROW), product (equipment and consumables), end-user (hospitals and biopharmaceutical companies and research centers), and application (predictive and diagnostic testing, prenatal, newborn, and preimplantation testing; pharmacogenomic testing; and forensic, relationship, and ancestry testing).

Gene Amplification Technologies Market – Global Gene Amplification Technologies Market by application (medical and pharmaceutical, forensic and identity testing, agricultural and food safety, and others) and geography (Asia, Europe, North America, and ROW).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191122005423/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email:media@technavio.com

Website:https://www.technavio.com

KEYWORD:

INDUSTRY KEYWORD: HEALTH GENETICS

SOURCE: Technavio Research

Copyright Business Wire 2019.

PUB: 11/22/2019 06:30 PM/DISC: 11/22/2019 06:30 PM

http://www.businesswire.com/news/home/20191122005423/en